Bristol-Myers Squibb Company And Pfizer Announce Charitable Donations Of More Than $1 Million To Support Cardiovascular Education For Patients And Caregivers

free biotech news Get the latest biotech news where you 

want it. Sign up for the free GenePool newsletter today!

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced charitable donations totaling more than $1 million to be granted between 2014 and 2016 to seven nonprofit organizations that support patients with cardiovascular disease. The donations will fund the independent development of innovative educational materials about stroke risk reduction in patients with nonvalvular atrial fibrillation (NVAF). The materials, accessible to both patients and caregivers, will address disease awareness, identification of signs and symptoms, access to care, appropriate treatment options, shared decision making and medication adherence. National Stroke Association, Heart Rhythm Society, American College of Physicians, American Heart Association Founders Affiliate, Regents of the University of Michigan/Society for Vascular Medicine, WomenHeart and American College of Emergency Physicians will each receive a charitable donation to support their independent educational initiatives.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC